A Study for Participants With Pancreatic Cancer

Clinical trial NCT00839332 · COMPLETED

Trial details

NCT number: NCT00839332
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pancreatic Neoplasms

Start date: 2009-02-01
Primary completion: 2013-02-01
Enrollment: 157

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.